Shares of Sintx Technologies (NASDAQ:SINT) shot up 4.8% on Thursday . The company traded as high as $2.70 and last traded at $2.60, 4,828 shares traded hands during trading. A decline of 98% from the average session volume of 256,767 shares. The stock had previously closed at $2.48.

A number of brokerages recently weighed in on SINT. Maxim Group restated a “hold” rating on shares of Sintx Technologies in a research report on Tuesday, September 24th. Ascendiant Capital Markets began coverage on Sintx Technologies in a research report on Wednesday, September 11th. They set a “buy” rating and a $3.00 price objective on the stock.

The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.30 and a current ratio of 2.34.

Sintx Technologies (NASDAQ:SINT) last issued its quarterly earnings data on Thursday, August 15th. The company reported ($3.99) earnings per share for the quarter. The company had revenue of $0.17 million during the quarter.

Sintx Technologies Company Profile (NASDAQ:SINT)

Sintx Technologies, Inc, a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications.

See Also: What is the Bid-Ask Spread?

Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with's FREE daily email newsletter.